Right now, try this. Stand facing a wall. Place your palms flat at shoulder height, elbows bent to about 90 degrees. Lean slightly into the wall and press — your triceps are working, but your elbow is NOT straightening. Hold 30 to 45 seconds, repeat 4 times. If you can do that with effort but pain at 3 out of 10 or below, you have a starting point.
The triceps anchors into your elbow bone through a wide, fan-shaped tendon — like rope frayed at the spot where it loops over a pulley. Heavy lockouts at the top of a bench press or a dip drag the rope across the pulley one more time each rep. The pain isn't the fraying. It's your nervous system flagging that the overnight repair crew can't keep up with the daily damage. Rest stops the damage but the repair crew never gets stronger; slow heavy loading trains the rope to take the work.
Posterior elbow pain at the back of the upper arm where the triceps inserts onto the olecranon — almost exclusively a lifter and thrower problem.
The triceps-specific RCT evidence does not exist. The protocol is class-extrapolated from lateral epicondylalgia, Achilles HSR (Beyer 2015), and insertional Achilles (Rompe 2008). The principle is uncontroversial across the tendinopathy class: progressive load, not rest.
Wall-press / band-resisted elbow extension mid-range hold. 25→70% MVC. 30–45 s × 4–5 sets, daily. Pain ≤ 3/10.
Cable triceps pushdown + modified skull-crusher (limited end-range). 3×10–15 RPE 4–6. 3-s eccentric. 2–3×/wk.
Heavy cable extension, weighted dip at controlled depth, close-grip bench (floor → board → pin → full). 3×6–8 RPE 7–8. 3-s eccentric. 2–3×/wk.
Drop close-grip bench, weighted dips, JM press. Substitute floor press / board press / pin-press. Continue lower-body and non-provocative upper-body at full load.
The active ingredient is not the lift selection. It is the rules: pain ≤ 3/10 during loading, return to baseline within 24 hours. Break either rule and step back one phase.
Extracorporeal shockwave therapy is supported by Rompe 2008 insertional Achilles class evidence and is the strongest refractory adjunct candidate for insertional patterns. Ultrasound-guided percutaneous tenotomy has direct triceps evidence: Furia 2017 (calcific triceps tendinosis in a competitive lifter, case report) and Wirth 2019 (mixed-elbow refractory cohort including triceps). Both reserved for cases that have completed 12+ weeks of compliant loading without progress, never as first-line.
Short-course NSAIDs and a single corticosteroid injection are a short-term diagnostic or pain-modulation bridge, never stand-alone treatment. Class evidence (Coombes 2010 Lancet pattern) shows short-term pain relief with long-term harm — repeated cortisone increases rupture risk and accelerates tendon degeneration. Pain neuroscience education addresses kinesiophobia in middle-aged male lifters and counters the "your triceps is degenerating" nocebo language that drives total rest.
Criterion-based, not date-based. Tick each box before progressing to full pressing volume.
Right now, try this. Stand facing a wall. Place your palms flat at shoulder height, elbows bent to roughly 90 degrees. Lean slightly into the wall and press — your triceps are working, but your elbow is NOT straightening. Hold 30 to 45 seconds, repeat 4 sets. If you can do that with effort but pain at 3 out of 10 or below, you have a starting point and a daily exercise.
High on the diagnostic framework: classify before treating, dynamometry as the decision gate, fluoroquinolone-statin-anabolic-steroid rupture-risk class, active loading beats rest.
Moderate on the extrapolated phased-loading protocol and on insertional-pattern rules at the olecranon.
Low on triceps-specific numeric dosing precision. Low-Moderate on ESWT and US-guided percutaneous tenotomy as refractory-only adjuncts.
Debunked-Low for total rest as first-line, repeated corticosteroid as stand-alone, and imaging-driven escalation in symptomatic-but-no-tear patients.
A triceps-specific RCT — 60 or more chronic distal triceps tendinopathy patients without partial tear on imaging, randomized to HSR (3×6–8 RPE 7–8 × 12 wk) vs sham loading vs wait-and-see, with primary endpoint a triceps-VISA equivalent at 12 and 52 weeks. Either a different optimal rep-load configuration or a null finding on HSR would force a rewrite of the dose-response table.
A large registry of 500-plus triceps tendinopathy presentations, stratifying outcomes by iatrogenic class exposure (fluoroquinolone, statin, AAS) versus non-iatrogenic, with rupture-conversion rates at 12 months. Would convert iatrogenic-class conviction from MODERATE direction to HIGH magnitude.
Join The Verdict for free weekly protocols on real-world rehab — sent every Sunday.
Get The Verdict freeThe distal triceps inserts as a wide, fan-shaped attachment over the olecranon — the bony point at the back of the elbow. That insertional architecture matters. Mechanically, the distal triceps insertion is closer to insertional Achilles tendinopathy than to mid-substance lateral epicondylalgia. Translation: the loading rules for insertional Achilles (modified-range progression, stronger ESWT response in refractory cases — Rompe 2008) apply here.
The pathology follows the Cook & Purdam tendinopathy continuum: reactive → tendon disrepair → degenerative tendinosis → partial tear → complete rupture. The drift along the continuum is driven by mismatch between tendon loading capacity and applied load, not by classical inflammation. Most chronic presentations are degenerative tendinosis, not tendinitis — which is why anti-inflammatory pharmacotherapy is symptom modulation, not treatment.
Three predictable contexts cause it. Heavy pressing-lockout work (close-grip bench, weighted dips, JM press, board press, heavy push-ups) repeatedly loads the olecranon insertion at end-range elbow extension. Forceful repetitive extension in throwing follow-through (javelin, baseball) loads the same insertion under sport-specific demand. Iatrogenic class membership — fluoroquinolones, statins, anabolic-androgenic steroids — alters tendon collagen architecture and accelerates progression along the continuum, with documented complete ruptures in the fluoroquinolone class evidence (Patel 2017).
Subjective hallmarks: aching at the back of the elbow localized to the olecranon, sharp pain on resisted elbow extension at end-range, history almost always names a specific lift (close-grip bench, weighted dips, JM press) or a throwing sport.
No triceps-specific Clinical Practice Guideline exists as of 2026-05-18. The OSU/Wexner Tendinopathy CPG is the closest governing framework. NICE and APTA have no triceps-tendinopathy-specific guidance. The conflicts below are between traditional teaching and the tendinopathy-paradigm class evidence.
"Rest until pain resolves, then return to activity." Standard pre-2010 orthopedic advice.
Active loading (isometric → concentric → HSR) is first-line. Total rest delays recovery. Class evidence: Beyer 2015, Rompe 2007. Cook & Purdam 2009 continuum is the operating model.
"Treat as inflammation. NSAIDs + steroid injection." Tendinitis framing.
Chronic tendon pathology is degenerative tendinosis, not classical inflammation. Repeated cortisone increases rupture risk. Coombes 2010 Lancet pattern. Loading first; cortisone only as a short-term bridge.
"Triceps responds like lateral epicondylalgia — apply tennis-elbow dosing rules." Magnussen 2003 narrative.
The olecranon insertion is mechanically closer to insertional Achilles. Modified-range loading and stronger ESWT response in refractory cases. Rompe 2008 insertional Achilles class evidence governs.
No exercise-based RCT in the retrieved literature uses triceps tendinopathy as the primary population. Every dosing parameter (rep ranges, tempo, frequency) is class-extrapolated from lateral epicondylalgia, Achilles tendinopathy, and the general tendinopathy CPG. The numbers are direction-supported and threshold-imprecise. Adjust by individual response, not by trial-prescribed numbers.
Class evidence comes from supervised physical-therapy cohorts. Most triceps presentations are recreational and competitive lifters who self-manage in the gym. Adherence to RPE-controlled tempo, pain-monitoring rules, and the 24-hour flare rule collapses under training-ego pressure. Coach the rules harder than the exercises — the rules are the active ingredient.
Fluoroquinolone, statin, and anabolic-androgenic steroid exposure are routinely missed at first presentation. Primary-care prescriptions of "activity" without medical review in these populations risk rupture conversion. Patel 2017 directly documents triceps ruptures following fluoroquinolone exposure. Screen at first session.
Surgery is reserved for the structural lesions: complete distal triceps rupture (urgent, 2 to 3 week window for best surgical outcomes) and persistent partial tear with extension strength deficit ≥ 50% that fails 3 months of compliant loading. Most triceps tendinopathy presentations in the lifting population resolve with phased conservative loading + lift substitution over 8 to 24 weeks. Refractory cases that have completed 12+ weeks of compliant loading without progress can escalate to ESWT or ultrasound-guided percutaneous tenotomy before surgical referral.
The dominant under-screened risk is iatrogenic class membership. A lifter who tweaked the back of his elbow last week and is on a 10-day course of ciprofloxacin needs the antibiotic flagged to his GP and a slower loading progression — not an aggressive Phase 3 protocol. The cost of missing this is rupture conversion. The cost of catching it is two minutes of history-taking.
Physio conditions reviewed against clinical evidence. What works, what doesn't, and what to do — from a practising physiotherapist.
Subscribe freeThe Verdict is built by the same team behind Precision Metrics — a physique and health coaching practice with 300+ clients coached. Dr. Seth Holbrook, DPT and Luke Holbrook lead the coaching.
Book a free consultationConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.